Bayer's Weinand On Pricing, Payers And Pipelines

 
• By Kevin Grogan
  
Deiter Weinand
Bayer's Pharma Chief Dieter Weinand implores broader value recognition for innovative medicines • Source: Bayer AG
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip